Viva Biotech Holdings (1873.HK) Earnings Analysis
Viva Biotech Holdings (1873.HK) next reports earnings on 2026-08-31. Trailing P/E 11.51.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1873.HK next report earnings?
| Next earnings date | 2026-08-31 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
1873.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-28 | 0.04855 HKD | n/a | n/a | n/a |
| 2024-08-29 | 0.05857 HKD | n/a | n/a | n/a |
1873.HK valuation and analyst view
| Trailing P/E | 11.51 |
|---|---|
| Trailing EPS | 0.08798 HKD |
| Price / book | 0.71 |
| Dividend yield | 0.00% |
| Market cap | 2.68B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Viva Biotech Holdings (1873.HK)'s next earnings date?
Viva Biotech Holdings is next scheduled to report on 2026-08-31.
Did 1873.HK beat earnings last quarter?
Consensus estimate data was not available for 1873.HK's 2025-08-28 report.
What is 1873.HK's current P/E ratio and EPS?
1873.HK trades at a trailing P/E of 11.51 on trailing EPS of 0.08798202397067423 HKD.
What do analysts rate 1873.HK?
1873.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.